Humacyte Inc (HUMA)
4.41
+0.01
(+0.23%)
USD |
NASDAQ |
May 03, 16:00
4.41
0.00 (0.00%)
After-Hours: 20:00
Humacyte Free Cash Flow: -75.58M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -75.58M |
| September 30, 2023 | -76.02M |
| June 30, 2023 | -79.54M |
| March 31, 2023 | -73.15M |
| December 31, 2022 | -72.18M |
| Date | Value |
|---|---|
| September 30, 2022 | -74.03M |
| June 30, 2022 | -87.62M |
| March 31, 2022 | -85.66M |
| December 31, 2021 | -81.41M |
Free Cash Flow Range, Past 5 Years
-87.62M
Minimum
Jun 2022
-72.18M
Maximum
Dec 2022
-78.35M
Average
-76.02M
Median
Sep 2023
Free Cash Flow Benchmarks
| Adial Pharmaceuticals Inc | -6.807M |
| Gritstone Bio Inc | -126.22M |
| Precision BioSciences Inc | -86.39M |
| Puma Biotechnology Inc | 14.37M |
| Revance Therapeutics Inc | -223.46M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.05M |
| Cash from Investing (Quarterly) | -0.15M |
| Cash from Financing (Quarterly) | -0.335M |
| Free Cash Flow Per Share (Quarterly) | -0.1853 |
| Free Cash Flow Yield | -16.57% |